We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Pacific Biosciences of California Inc | NASDAQ:PACB | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.18 | -8.22% | 2.01 | 2.01 | 2.04 | 2.19 | 2.00 | 2.17 | 8,137,826 | 00:59:53 |
| | |
Public
Offering Price |
| |
Discounts and
Commissions(1) |
| |
Proceeds to Pacific
Biosciences of California, Inc. (before expenses) |
| |||||||||
Per Share
|
| | | $ | 10.00 | | | | | $ | 0.575 | | | | | $ | 9.425 | | |
Total
|
| | | $ | 175,000,000 | | | | | $ | 10,062,500 | | | | | $ | 164,937,500 | | |
|
GOLDMAN SACHS & CO. LLC
|
| |
MORGAN STANLEY
|
| | COWEN | | |
ALLEN & COMPANY LLC
|
|
| | |
Page
|
| |||
| | | | S-ii | | | |
| | | | S-1 | | | |
| | | | S-6 | | | |
| | | | S-7 | | | |
| | | | S-9 | | | |
| | | | S-10 | | | |
| | | | S-11 | | | |
| | | | S-12 | | | |
| | | | S-16 | | | |
| | | | S-23 | | | |
| | | | S-23 | | | |
| | | | S-24 | | | |
| | | | S-24 | | |
| | | | | ii | | | |
| | | | | 1 | | | |
| | | | | 4 | | | |
| | | | | 5 | | | |
| | | | | 6 | | | |
| | | | | 7 | | | |
| | | | | 8 | | | |
| | | | | 9 | | | |
| | | | | 16 | | | |
| | | | | 19 | | | |
| | | | | 20 | | | |
| | | | | 21 | | | |
| | | | | 22 | | | |
| | | | | 23 | | | |
| | | | | 25 | | | |
| | | | | 25 | | | |
| | | | | 25 | | | |
| | | | | 26 | | |
|
Public offering price per share
|
| | | | | | | | | $ | 10.00 | | |
|
Net tangible book deficit per share as of September 30, 2022
|
| | | $ | (0.86) | | | | | | | | |
|
Increase in net tangible book value per share attributable to new investors after giving effect to the offering
|
| | | | 0.74 | | | | | | | | |
|
Net tangible book deficit per share after giving effect to the offering
|
| | | | | | | | | | (0.12) | | |
|
Dilution in net tangible book value per share to new investors in this offering
|
| | | | | | | | | $ | 10.12 | | |
Underwriters
|
| |
Number of
Shares |
| |||
Goldman Sachs & Co. LLC
|
| | | | 6,125,000 | | |
Morgan Stanley & Co. LLC
|
| | | | 5,250,000 | | |
Cowen and Company, LLC
|
| | | | 3,500,000 | | |
Allen & Company LLC
|
| | | | 2,625,000 | | |
Total
|
| | | | 17,500,000 | | |
Paid by Us
|
| |
No Exercise
|
| |
Full Exercise
|
| ||||||
Per Share
|
| | | $ | 0.575 | | | | | $ | 0.575 | | |
Total
|
| | | $ | 10,062,500 | | | | | $ | 11,571,875 | | |
| | |
Page
|
| |||
| | | | ii | | | |
| | | | 1 | | | |
| | | | 4 | | | |
| | | | 5 | | | |
| | | | 6 | | | |
| | | | 7 | | | |
| | | | 8 | | | |
| | | | 9 | | | |
| | | | 16 | | | |
| | | | 19 | | | |
| | | | 20 | | | |
| | | | 21 | | | |
| | | | 22 | | | |
| | | | 23 | | | |
| | | | 25 | | | |
| | | | 25 | | | |
| | | | 25 | | | |
| | | | 26 | | |
1 Year Pacific Biosciences of C... Chart |
1 Month Pacific Biosciences of C... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions